{"nct_id":"NCT04344795","title":"Phase 1a/1b Study of TPST-1495 as a Single Agent and in Combination With Pembrolizumab in Subjects With Solid Tumors","status":"COMPLETED","status_verified_date":"2025-09","start_date":"2020-05-06","start_date_type":"ACTUAL","primary_completion_date":"2024-09-25","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["TPST"]}